FDA gives Sanofi TB drug another approval; Italian court upholds antitrust fines against Roche, Novartis;

@FiercePharma: ICYMI yesterday: Reuters: In Fresenius, Danone could lose second suitor for nutrition unit. Item | Follow @FiercePharma

@CarlyHFierce: Reuters: In Fresenius, Danone could lose second suitor for nutrition unit. More | Follow @CarlyHFierce

> The FDA has approved Sanofi's ($SNY) Priftin in combination with isoniazid for a new indication, in the treatment of latent tuberculosis infection. Story

> Italy's Lazio regional administrative court on has upheld an antitrust fine of €180 million against Novartis ($NVS) and Roche ($RHHBY), accused of forming a cartel to promote the more expensive eye drug Lucentis over Roche's Avastin. Report

> The European Medicines Agency will look for a new executive director after Guido Rasi stepped aside following a EU commission decision that his selection was flawed. Story

> Ranbaxy Laboratories is reportedly in talks with the Competition Commission of India about what products it might sell there to gain approval of its merger with Sun Pharmaceutical. Story

> GW Pharmaceuticals blamed higher R&D costs for steeper full-year losses.

Medical Device News

@FierceMedDev: ICYMI yesterday: Medtronic gets EU regulatory green light for $43 billion merger with Covidien. Article | Follow @FierceMedDev

@EmilyWFierce: Roche acquires prenatal diagnostics outfit Ariosa. Press release | Follow @EmilyWFierce

> Medtronic sells $17B in bonds to fund Covidien buy. Story

> Masimo wireless, wearable patient monitor cleared by FDA. More

> Edison Nation and Mount Sinai team up for device innovation. Article

> FDA approves Animas insulin pump, continuous glucose monitor combo device. Report

Biotech News

@FierceBiotech: From FierceBiotechIT: Texas' $3B cancer agency makes computational biology a priority. Article | Follow @FierceBiotech

@JohnCFierce: I wonder if someone would pay me $3.5B for Uncle John's Quiet Time Elixir. (Nyquil and bourbon). $AVNR. | Follow @JohnCFierce

@DamianFierce: Tim Duncan donated $247K to help sequence the genomes of 1,000 cancer patients and publicize the results. Article | Follow @DamianFierce

> J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III. News

> GeNeuro snags a $455M deal, inks MS drug pact with Servier. More

> Otsuka buys Avanir and its portfolio of repurposed generics for $3.5B. Story

> Ascendis banks $60M to get its orphan drug into Phase III. Article

Biotech Research News

> New structural biology software tackles viruses and bacteria. Story

> 8-year study highlights role of a key protein in cardiomyopathy. More

> Binge drinking 'cure' in rats sparks a debate over animal study. Story

> Cell research at Brigham & Women's points to a new drug target for fibrosis. Report

> Harvard, MIT teams identify a 'pre-malignant' phase for blood cancers. Article

Pharma Manufacturing News

> Lyophilization market forecast to double in size by 2020. Article

> FDA slaps Dr. Reddy's with a Form 483. Report

> Eisai opens new plants targeting Asia and Europe. More

> Italy clears Novartis vaccine manufacturing in deaths following vaccinations. Story

> Recipharm expands footprint, buys Flamel facility in France for $13.2M. Article

And Finally... People diagnosed with diabetes in their 50's are significantly more likely than others to suffer mental decline by their 70's, researchers have found. More